22 September, 2026 | Tuesday BioPharma America BioPharma Europe BioPharma Middle East BioPharma Africa Every First Approval in APAC, 2026: The Full List WuXi XDC Achieves GMP Release for Singapore Bioconjugate Manufacturing Site Accro Bio Doses First Patient in Phase IIb Trial of RIPK2 Inhibitor AC-101 for Ulcerative Colitis DKSH Launches Colpofix in Singapore to Support Women with HPV-Related Cervical Lesions Telix to Merge with ITM in $1.65B Deal, Building Global Radiopharmaceutical Powerhouse Specialised Therapeutics, Incyte Expand Partnership to Bring Ruxolitinib Cream to Australia 16 September, 2026 | Wednesday | News Ecolab Life Sciences Opens New Resin Manufacturing Facility in China Demand for advanced purification solutions is growing as industries look to improve performance while using less water and fewer natural resources. Industries are increasingly turning to advanced separation, pu... 21 September, 2026 | Monday | News OGT Expands SureSeq NGS Indexing Capacity to 384 Samples per Run OGT, a leading global provider of genomic research and diagnostic solutions, announced the expansion of its SureSeq™ Universal NGS Unique Dual Index (UDI) range, enabling laboratories to multiplex up to 3... 22 September, 2026 | Tuesday | News Telix to Merge with ITM in $1.65B Deal, Building Global Radiopharmaceutical Powerhouse Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufac... Contract Services 22 September, 2026 | Tuesday | News WuXi XDC Achieves GMP Release for Singapore Bioconjugate Manufacturing Site WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, today held a grand GMP releas... Consumer Health 22 September, 2026 | Tuesday | News DKSH Launches Colpofix in Singapore to Support Women with HPV-Related Cervical Lesions Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infection, with DKSH's launch of Colpofix®. The vaginal spray gel medical device is indicated... 17 September, 2026 | Thursday | News Ferronova’s Nanoparticle Platform Shows Promise for More Precise Gastric and Oesophageal Cancer Surgery Australian medical technology company Ferronova has announced preliminary findings from the MAGMAP multi-centre trial involving 62 gastric and oesophageal patients evaluating the safety and feasibility of ... 21 September, 2026 | Monday | News OGT Expands SureSeq NGS Indexing Capacity to 384 Samples per Run OGT, a leading global provider of genomic research and diagnostic solutions, announced the expansion of its SureSeq™ Universal NGS Unique Dual Index (UDI) range, enabling laboratories to multiplex up to 3... 22 September, 2026 | Tuesday | Analysis Every First Approval in APAC, 2026: The Full List

Product Spot Light 17 September, 2026 | Thursday | News Waters Launches BD FACSDiscover A7 Cell Analyzer to Expand Access to Advanced Flow Cytometry Premium Article 22 September, 2026 | Tuesday | Analysis Every First Approval in APAC, 2026: The Full List 14 September, 2026 | Monday | News Novo Holdings Makes Strategic Investment in China’s Wound Care CDMO ForYou Medical Biopharma APAC Infomercial Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out? The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail. APAC's Peptide-Capacity Gamble After the Rush: APAC's mRNA and Vaccine Capacity Hangover The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy? The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies? Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck Can APAC Build Radioligand Therapy Before the Atoms Decay? The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026 Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC? Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next The Frontier That Won’t Quite Arrive Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production Two Chairs, 11,000 Kilometres Apart: The Human Cost of Asia’s Plasma Dependence China Plus One: Slogan, Strategy, or Capacity APAC Does Not Have? The Technology Is Ready. Are APAC’s Regulators? Sign up to our free newsletter and get the latest news sent direct to your inbox Advertise with us Contact the Editor Content Planner 2026 Forgot your password? Lost your password? Please enter your email address. You will receive a link to create a new password.